Olink® Proteomics
Olink® Proteomics, part of Thermo Fisher Scientific is a global biotechnology company dedicated to providing advanced products and services that enable new discoveries into human health and disease. Olink's innovative solutions deliver highly sensitive,...
Read More
Website
-
JAN 15, 2025 | 7:00 AM
Grab your cup of coffee and join us for the next Multiomics Coffee Break on 15th January at 10.00AM EST/4.00PM CET, with a presentation from Discovery Life Sciences, an Olink Certified Servi... -
JAN 30, 2025 | 1:00 PM
In this webinar, Dr. Clarissa Yates, CEO of Ketim Therapeutics, will share her exciting results from a proteomics pilot study exploring biomarkers associated with postpartum depression (PPD)...
-
FEB 04, 2025 | 7:00 AM
Protein biomarker discovery, validation and utilization require technologies that deliver proteome insights with breadth and depth. Liquid chromatography mass spectrometry (LC-MS), the gold-...
-
DEC 11, 2024 | 8:00 AM
Precision Diagnosis of Ovarian Cancer – Identification of Protein Biomarkers that Separate Benign from Malignant Tumors Ovarian cancer has the highest mortality among gynecological can...
-
DEC 05, 2024 | 8:00 AM
Tuberculosis (TB) remains a disease of global significance, causing 1.3 million deaths and 10.6 million cases of active disease worldwide each year. The World Health Organization (WHO) has i...
-
OCT 02, 2024 | 11:00 AM
Inflammatory skin disorders comprise a diverse set of conditions exhibiting unique characteristics. Our objective was to systematically compare the affected and unaffected skin of individual...
-
JUN 26, 2024 | 12:00 PM
Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, is characterized by malignant T-cell skin infiltration leading to inflammation and skin barrier defects. To effecti...
-
JUN 11, 2024 | 8:00 AM
Cancer genome alterations that cause cancer cells to grow also confer vulnerabilities, which normal cells lack. The challenge is that, for the majority of cancers, we do not understand the r...
-
MAY 30, 2024 | 9:00 AM
Long COVID, now recognized as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), represents a significant and growing concern in public health and medical communities. As the COVID-19 pande...
-
APR 24, 2024 | 6:00 AM
Over the past few decades, protein analysis and proteomics have emerged as crucial tools in disease risk assessment, providing a more holistic understanding of susceptibility to diseases and...
-
MAR 12, 2024 | 10:00 AM
Inflammation is associated with cognitive decline and the pathogenesis of Alzheimer's disease, although exact pathways remain elusive. To further explore the role of inflammation, we uti...
-
FEB 21, 2023 | 8:00 AMC.E. CREDITS
Date: February 21, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Cancer is a highly heterogeneous disease in need of accurate and non-invasive diagnostic tools. Here, we describe a no...
-
JAN 25, 2023 | 8:00 AM
Date: January 25, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Allogeneic hematopoietic cell transplantation (HCT) is curative for hematological diseases; however, is also associated...
